Li, X., Fang, T., Xu, S., Jin, P., Zhou, D., Wang, Z., . . . Gao, Q. (2021). PARP inhibitors promote stromal fibroblast activation by enhancing CCL5 autocrine signaling in ovarian cancer. Nature Portfolio.
Chicago Style (17th ed.) CitationLi, Xiaoting, et al. PARP Inhibitors Promote Stromal Fibroblast Activation by Enhancing CCL5 Autocrine Signaling in Ovarian Cancer. Nature Portfolio, 2021.
MLA (8th ed.) CitationLi, Xiaoting, et al. PARP Inhibitors Promote Stromal Fibroblast Activation by Enhancing CCL5 Autocrine Signaling in Ovarian Cancer. Nature Portfolio, 2021.
Warning: These citations may not always be 100% accurate.